26
Participants
Start Date
October 17, 2018
Primary Completion Date
January 15, 2021
Study Completion Date
AZD6738
AZD6738 160mg QD
Olaparib
Olaparib 300mg BID
Samsung Medical Center, Seoul
Samsung Medical Center
OTHER